A newcomer to the SBIR arena in 2021, NanoPin Technologies, Inc is structured around advancing infectious disease diagnosis and improve patient care through the use of novel diagnostic platforms designed rapidly to produce accurate results from patient samples. Loacted in Gilber AZ at the time of award, the firm is reloated to The firm's versatile platforms are anchored in the need to address critical aspects of current infectious disease epidemics to include tuberculosis - historically the leading cause of death worldwide from infectious disease - HIV, and COVID-19.
